Treatment for superficial thrombophlebitis of the leg

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 4, 2013, Pages

  Di Nisio, Marcello ^a,b   Wichers, Iris M ^c   Middeldorp, Saskia ^b  

^a UNIVERSITY OF CHIETI   (Italy)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Healthcare Center Borgerstraat   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACEMETACIN; ANTIVITAMIN K; DEFIBROTIDE; DESMIN; DICLOFENAC; EPINEPHRINE; FONDAPARINUX; HEPARAN SULFATE; HEPARIN; HEPARIN CALCIUM; INDOMETACIN; LOW MOLECULAR WEIGHT HEPARIN; MONOXERUTIN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; SULODEXIDE; ANTICOAGULANT AGENT; POLYSACCHARIDE;

BLEEDING; CLINICAL EFFECTIVENESS; DEEP VEIN THROMBOSIS; ENZYME THERAPY; HUMAN; LEG; LUNG EMBOLISM; MORTALITY RATE; PRIORITY JOURNAL; REVIEW; SUPERFICIAL THROMBOPHLEBITIS; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; THROMBECTOMY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; VISUAL ANALOG SCALE; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); THROMBOEMBOLISM; THROMBOPHLEBITIS; VENOUS THROMBOEMBOLISM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; POLYSACCHARIDES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOEMBOLISM; THROMBOPHLEBITIS; VENOUS THROMBOEMBOLISM;

EID: 84886838629     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD004982.pub5     Document Type: Review

References (98)

1. Andreozzi GM, Signorelli S, Di Pino L, Martini R, Marchitelli E, Pinto A, et al. Tolerability and clinical efficacy of desmin in the treatment of superficial varicothrombophlebitis. Angiology 1996;47(9):887-94.
2. Anonymous. Indomethacin in superficial thrombophlebitis. The Practitioner 1970;205(227):369-72.
3. Archer DS, Fowler PD. Comparison of oxyphenbutazone and placebo in the treatment of superficial thrombophlebitis: an object lesson in clinical trial design. The Practitioner 1977;218:712-75.
4. Belcaro G, Errichi BM, Laurora G, Cesarone MR, Candiani C. Treatment of acute superficial thrombosis and follow-up by computerized thermography. VASA 1989;18(3):227-34.
5. Belcaro G. Evolution of superficial vein thrombosis treated with defibrotide: comparison with low dose subcutaneous heparin. International Journal of Tissue Reactions 1990;12(5):319-24.
6. Belcaro G, Nicolaides AN, Errichi BM, Cesarone MR, De Sanctis MT, Incandela L, et al. Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study. Angiology 1999;50(7):523-9.
7. Belcaro G, Cesarone MR, Dugall M, Feragalli B, Ippolito E, Corsi M, et al. Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. Panminerva Medica 2011;53(3 Suppl 1):3-11.
8. Cosmi B, Filippini M, Tonti D, Avruscio G, Ghirarduzzi A, Bucherini E, et al. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). Journal of Thrombosis and Haemostasis 2012;10(6):1026-35.
9. Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, et al. CALISTO Study Group. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. New England Journal of Medicine 2010;363(13):1222-32.
10. De Sanctis MT, Cesarone MR, Incandela L, Belcaro G, Griffin M. Treatment of superficial vein thrombosis with standardized application of Essaven gel -- a placebo-controlled, randomized study. Angiology 2001;52 Suppl 3:S57-62.
11. Ferrari E, Pratesi C, Scaricabarozzi I, Trezzani R. A clinical study of efficacy and tolerability of nimesulide compared with diclofenac sodium in the treatment of acute superficial thrombophlebitis [Studio clinico sull'efficacia terapeutica e la tollerabilità della nimesulide in confronto a diclofenac sodio nel trattamento delle tromboflebiti acute superficiali]. Minerva Cardioangiologica 1992;40(11):455-60.
12. Gorski G, Szopinski P, Michalak J, Marianowska A, Borkowski M, Geremek M, et al. Liposomal heparin spray: a new formula in adjunctive treatment of superficial venous thrombosis. Angiology 2005;56(1):9-17.
13. Holzgreve A, Kleine W, Stegmann W. Local treatment of superficial thrombophlebitis with nonsteroidal antiinflammatory agents. Zeitschrift fur Allgemeinmedizin 1989;65(27):663-7.
14. Incandela L, De Sanctis MT, Cesarone MR, Ricci A, Errichi BM, Dugal M, et al. Treatment of superficial vein thrombosis: clinical evaluation of essaven gel--a placebo-controlled, 8-week, randomized study. Angiology 2001;52 Suppl 3:69-72.
15. Katzenschlager R, Ugurluoglu A, Minar E, Hirschl M. Liposomal heparin-spraygel in comparison with subcutaneous low molecular weight heparin in patients with superficial venous thrombosis. A randomized, controlled, open multicentre study. Journal fur Kardiologie 2003;10(9):375-8.
16. Koshkin VM, Kirienko AI. Systemic enzyme therapy in the treatment of acute thrombosis of superficial veins in the lower extremities and postthrombophlebitic disease. International Journal of Immunotherapy 2001;17(2-4):121-4.
17. Kuhlwein A. Drug treatment of superficial thrombophlebitides [Medikamentose behandlung oberflachlicher thrombophlebitiden]. Therapiewoche 1985;35(36):4067-70.
18. Lozano FS, Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. Vascular and Endovascular Surgery 2003;37(6):415-20.
19. Marchiori A, Verlato F, Sabbion P, Camporese G, Rosso F, Mosena L, et al. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study. Haematologica 2002;87(5):523-7.
20. Marshall M, Kleine M-W. Efficacy and tolerability of an oral enzyme therapy in the treatment of painful acute superficial thrombophlebitis [Wirksamkeit und vertraglichkeit einer oralen enzymtherapie bei der schmerzhaften akuten thrombophlebitis superficialis]. Phlebologie 2001;30(2):36-43.
21. Messa G, La Placa G, Puccetti L, Di Perri T. Heparansulphate. Effectiveness and tolerability of heparan sulphate in the treatment of superficial thrombophlebitis. Controlled clinical study vs sulodexide [Efficacia e tollerabilità dell'eparansolfato nel trattamento della tromboflebite superficiale. Studio clinico controllato vs sulodexide]. Minerva Cardioangiologica 1997;45(4):147-53.
22. Nocker W, Diebschlag W, Lehmacher W. The efficacy of a diclofenac gel compared with placebo and heparin gel in the local treatment of superficial thrombophlebitis [Lokaltherapie bei oberflachlicher thrombophlebitis. Wirksamkeit eines diclofenac-natrium-gels im vergleich zu placebo- und heparin-gel]. Zeitschrift fur Allgemeinmedizin 1991;67:2214-22.
23. Nusser C-J, Schare W, Bernard I. The treatment of superficial thrombophlebitis with nonsteroidal antiphlogistic agents [Therapie superfizieller thrombophlebitiden mit nichtsteroidalen antiphlogistika]. Therapiewoche 1991;41(9):541-4.
24. Pinto G, Galati D, Bompiani GD, Corcione F, Califano G, Colucci S, et al. Topical 5'-methylthioadenosine in the treatment of symptomatic chronic venous insufficiency, haemorrhoids and superficial phlebitis. A double-blind placebo-controlled trial. Drug Investigation 1992;4(3):205-14.
25. Rathbun SW, Aston CE, Whitsett TL. A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis. Journal of Thrombosis and Haemostasis 2012;10(5):833-9.
26. Superficial Thrombophlebitis Treated by Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Archives of Internal Medicine 2003;163(14):1657-63.
27. Titon JP, Auger D, Grange P, Hecquet JP, Remond A, Ulliac P, Vaissie JJ. Therapeutic management of superficial venous thrombosis with calcium nadroparin. Dosage testing and comparison with an non-steroidal anti-inflammatory agent [Traitement curatif des thromboses veineuses superficielles par nadroparine calcique. Recherche posologique et comparaison à un anti-inflammatoire non stéroidien]. Annales de Cardiologie et d'Angeiologie 1994;43(3):160-6.
28. Uncu H. A comparison of low-molecular-weight heparin and combined therapy of low-molecular-weight heparin with an anti-inflammatory agent in the treatment of superficial vein thrombosis. Phlebology 2009;24(2):56-60.
29. Prandoni P. High versus low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs. A double-blind, randomized trial. http://www.blackwellpublishing.com/isth2005/abstract.asp?id=46005. 2005; Vol. 3.
30. Prandoni P, Tormene D, Pesavento R. Vesalio Investigators Group. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial. Journal of Thrombosis and Haemostasis 2005;3(6):1152-7.
31. Winter WR, Rauhut K, Arnold S, Babiak D, Stoidner B. Local therapy of thrombophlebitis superficialis - An inter-individual comparison of Voltaren-Emulgel versus a gel containing heparin [Lokale therapie der thrombophlebitis superficialis-Ein individueller vergleich von Voltaren-emulgel versus ein heparin-haltiges gel]. Zeitschrift fur Rheumatologie 1986;45:180-1.
32. Agus GB, de Angelis R, Mondani P, Moia R. Double-blind comparison of nimesulide and diclofenac in the treatment of superficial thrombophlebitis witht telethermographic assessment. Drugs 1993;46 Suppl 1:200-3.
33. Allegra C, Pollari G, Criscuolo A, Bonifacio M, Tabassi D. Centella asiatica extract in venous disorders of the lower limbs. Comparative clinical-instrumental trial against a placebo [L'estratto di centella asiatica nelle flebopatie degli arti inferiori. Ricerca clinico-strumentale comparativa con un placebo]. Clinica Terapeutica 1981;99:507-13.
34. Annoni F, De Stefano A, Pabisch S, Floresta M, Magnani P, Lietti F, et al. Efficacy and safety of topical treatment with heparan sulfate in superficial phlebitis. A double-blind placebo-controlled trial. Acta Therapeutica 1991;17:263-72.
35. Argenteri A, Vittori F, Longoni A. Flurbiprofen and thrombophlebitis of lower limbs: a controlled clinical trial [Terapia antiinfiammatoria delle tromboflebiti degli arti inferiori con flurbiprofen: studio clinico controllato]. Giornale Italiano di Angiologia 1983;3:203-8.
36. Bagliani A, La Rosa A, Sarchi C. A new anti-inflammatory drug, suprofen, in the treatment of thrombophlebitis [Un nuovo farmaco antiinfiammatorio, il suprofen, nel trattamento delle tromboflebiti]. Giornale Italiano di Angiologia 1983;3:57-64.
37. Becherucci A, Bagilet D, Marenghini J, Diab M, Biancardi H. Effect of topical and oral diclofenac on superficial thrombophlebitis caused by intravenous infusion [Efecto del diclofenaco topico y oral sobre la tromboflebitis superficial inducida por infusion intravenosa]. Medicina Clinica 2000;114(10):371-3.
38. Bergqvist D, Brunkwall J, Jensen N, Persson NH. Treatment of superficial thrombophlebitis. A comparative trial between placebo, hirudoid cream and piroxicam gel. Annales Chirurgiae et Gynaecologiae 1990;79(2):92-6.
39. Bernicot J. The value of Eucatex in venous pathology in the young woman [Interet d'eucatex dans la pathologie veineuse de la jeune femme]. Quest Medical 1980;33(5):221-2.
40. Bracale G, Selvetella L. Controlled clinical trial comparing seaprose S to serratio-peptidase in venous inflammatory disease. Efficacy and safety [Studio clinico sull'efficacia e la tollerabilità del seaprose S nelle flebopatie infiammatorie. Studio controllato verso serratio-peptidasi]. Minerva Cardioangiologica 1996;44(10):515-24.
41. Bruni M, Quarti Trevano GM, Lochis D, Baresi A, Soletti L. Double-blind assessment of the clinical and pharmacological results of administration of a preparation with trypsin/chymotrypsin and tetracycline hydrochloride base in cases of acute phlebitis [Analisi in doppio cieco dei risultati clinici e farmacologici dopom somministrazione di un preparato a base di tripsina/chimotripsina e tetraciclina cloridrato nelle flebiti acute]. Gazzetta Medica Italiana 1979;138(11):567-70.
42. Della Marchina M, Renzi G, Palazzini E. Treatment of phlebopathies with low molecular weight heparin as compared to heparin calcium. Riforma Medica 1989;104(4):99-104.
43. Di Perri T, Vittoria A, Messa GL, Cappelli R. Defibrotide therapy for thrombophlebitis -- controlled clinical trial. Haemostasis 1986;16 Suppl 1:42-7.
44. Gandhi DB, Palmar JR, Lewis B, Schraibman IG. Clinical comparison of elastic supports for venous diseases of the lower limbs. Postgraduate Medical Journal 1984;60:349-52.
45. Giorgetti PL, Bortolani EM, Morbidelli A, Vandone PL, Ghilardi G, Mattioli A, et al. Use of a new anti-inflammatory drug in the treatment of varicophlebitis of the lower limbs [L'uso di un nuovo farmaco antiinflammatorio nel trattamento delle varicoflebiti degli arti inferiori]. Minerva Chirurgica 1990;45(12):883-6.
46. Gouping Z, Wan-Er T, Xue-Ling W, Min-Qian X, Kun F, Turale S, et al. Notoginseny cream in the treatment of phlebitis. Journal of Infusion Nursing 2003;26(1):49-54.
47. Ibanez-Bermudez S, Perez Martinez F, Llamas del Castillo MD, Sevilla Jiménez JC, Gonzalez Gonzalez EM. Randomized double-blind clinical study on the efficacy of topical sodium heparin versus sodium polysulphate pentosan [Estudio clinico randomizado y doble ciego sobre la eficacia de heparina sodica topica frente a pentosan polisulfato sodico en patologias venosas superficiales]. Farmacia e Clinica 1996;13(2):110-5.
48. Luttichau U, Palazzini E. Antithrombotic therapy in phlebopathies of lower limbs: a controlled study of low molecular weight heparin versus heparin calcium. Rivista Europea Per Le Scienze Mediche e Farmacologiche 1989;11(4):351-8.
49. Mari F, Cerreta G, Nardi V, Dialti L. Piroxicam as antiinflammatory therapy in thrombophlebitis: clinical experience [Il piroxicam nella terapia antiflogistica delle tromboflebiti. Nostra esperienza clinica]. Gazzetta Medica Italiana 1982;141(5):243-5.
50. Marsala F. A controlled double-blind cross-over study of a calcium heparin preparation [Studio controllato in doppio cieco cross-over su un preparato a base di calcio-eparina]. Clinica Terapeutica 1985;113(6):473-7.
51. Mauro M, Ferraro G, Palmieri G. Profibrinolytic and antithrombotic effects of sulodexide oral administration: a double-blind, cross-over, placebo-controlled study. Current Therapeutic Research, Clinical and Experimental 1992;51(3):342-50.
52. Mehta PP, Sagar S, Kakkar VV. Treatment of superficial thrombophlebitis: a randomized double-blind trial of heparinoid cream. BMJ 1975;3(5984):614-6.
53. Paciaroni E, Marini M. Topical therapy for phlebophaties. Results of a controlled clinical study [Sulla terapia topica delle flebopatie. Risultati di uno studio clinico controllato]. Policlinico Sezione Medica 1982;89(3):255-64.
54. Porters J, Roekaerts F, Reyntjens A. R 41 468, a specific serotonin antagonist, relieves symptoms of acute superficial thrombophlebitis. Current Therapeutic Research, Clinical and Experimental 1981;30(4):499-506.
55. Pozza E, Menghi R, Pansini GC, Duatti A, Carnovali M. Clinical trial with BPH 689 for the treatment of superficial phlebitis [Impiego clinico del BPH 689 nel trattamento delle flebiti superficiali]. Acta Chirurgica Italiana 1980;36(2):157-66.
56. Rea WJ, Peters DW, Smiley RE, Edgar R, Greenberg M, Fenyves E. Recurrent environmentally triggered thrombophlebitis: a five-year follow-up. Annals of Allergy 1981;47(5):338-44.
57. Resta V. Clinical comparative experiment on 2 ointments of different extractive heparinoid concentrations (double blind test). Arzneimittel-Forschung 1967;17(8):1078-82.
58. Rozsos I, Kollar L, Scholz ME. The topical treatment of infusion thrombophlebitis with pentosan polysulfate sodium ointment. A randomised double-blind study. Annals of Hematology 1994;68 Suppl 1:A92.
59. Seccia M, Bortolotti P, Bellomini MG, Buccianti P, Chiarugi M, Cavina E. Use of defibrotide in the treatment of acute superficial thrombophlebitis of the legs [Impiego del defibrotide nel trattamento delle tromboflebiti acute superficiali degli arti]. Minerva Chirurgica 1989;44(9):1379-84.
60. Seghezzi R, Borri P, Chierichetti S, Ferrari P. Controlled clinical trial of 4-prenyl-1, 2-diphenyl-3, 5-pyrazolidinedione (DA2370) and oxyphenbutazone in thrombophlebitis. Arzneimittel-Forschung 1972;22(1):272-4.
61. Seligman B. Oral bromelains as adjuncts in the treatment of acute thrombophlebitis. Angiology 1969;20(1):22-6.
62. Stolle A. Treatment of superficial thrombophlebitis with a new emulsion gel [Behandlung der thrombophlebitis superficialis mit einem neuartigen emulsiongel]. Die Medizinische Welt 1986;37:700-2.
63. Tomamichel M, Reiner M. Treatment of thrombophlebitis and superficial phlebitis. A comparison of nimesulide and oxyphenbutazone. Clinical Trials Journal 1983;20(3):148-57.
64. van Cauwenberge H. Double-blind study of the efficacy of a soluble rutoside derivative in the treatment of venous disease [Etude n double aveugle de l'efficacité de l'O-(beta-hydroxyéthyl)-rutosides dans le traitement des affections veineuses]. Archives Internationales de Pharmacodynamie et de Therapie 1972;196:122-8.
65. van der Knaap JH, den Ottolander GJH, van Heerde LR. Research into efficacy of heparinoid cream [Onderzoek naar de effectiviteit van heparinodezalf]. Pharmaceutisch Weekblad 1988;123:973-5.
66. Bijuan L. Observation of aloe pigmentum in treatment of phlebitis. Nanfang Journal of Nursing 2003, (3).
67. Rabe E. DAPS-dalteparin in patients with superficial leg vein phlebitis in addition to compression treatment - a placebo-controlled phase-III study. XVIth World Meeting of the Union Internationale de Phlébologie (UIP), Principality of Monaco. August 31-September 4, 2009.
68. Barrelier MT. Superficial venous thrombosis of the legs. Phlebologie 1993;46(4):633-9.
69. Bergqvist D, Jaroszewski H. Deep venous thrombosis in patients with superficial thrombophlebitis of the leg. British Medical Journal 1986;292(6521):658-9.
70. Blumenberg RM, Barton E, Gelfand ML, Skudder P, Brennan J. Occult deep venous thrombosis complicating superficial thrombophlebitis. Journal of Vascular Surgery 1998;27(2):338-43.
71. Bounameaux H, Reber-Wasem MA. Superficial thrombophlebitis and deep venous thrombosis. A controversial association. Archives of Internal Medicine 1997;157(16):1822-4.
72. Chengelis DL, Bendick PJ, Glover JL, Brown OW, Ranval TJ. Progression of superficial venous thrombosis to deep vein thrombosis. Journal of Vascular Surgery 1996;24(5):745-9.
73. de Moerloose P, Wutschert R, Heinzmann M, Perneger T, Reber G, Bounameaux H. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, Factor II G20210A and overweight. Thrombosis and Haemostasis 1998;80(2):239-41.
74. De Weese MS. Nonoperative treatment of acute superficial thrombophlebitis and deep femoral venous thrombosis. In: Ernst C B, Stanley J C editor(s). Current Therapy in Vascular Surgery. 2nd Edition. Philadelphia: B C Decker, 1991.
75. Decousus H, Quéré I, Presles E, Becker F, Barrellier M, Chanut M, et al. POST (Prospective Observational Superficial Thrombophlebitis) Study Group. Superficial venous thrombosis and venous thromboembolism. Annals of Internal Medicine 2010;152(4):218-24.
76. Goldman L, Ginsberg J. Superficial phlebitis and phase 3.5 trials. New England Journal of Medicine 2010;363(13):1278-80.
77. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6.
78. Hanson JN, Ascher E, De Pippo P, Lorensen E, Scheinman M, Yorkovich W, et al. Saphenous vein thrombophlebitis (SVT): a deceptively benign disease. Journal of Vascular Surgery 1998;27(4):677-80.
79. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
80. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Chichester: John Wiley & Sons.
81. Jorgensen JO, Hanel KC, Morgan AM, Hunt JM. The incidence of deep venous thrombosis in patients with superficial thrombophlebitis of the lower limbs. Journal of Vascular Surgery 1993;18(1):70-3.
82. Juni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323(7303):42-6.
83. Krunes U, Lindner F, Lindner R, Gnutzmann J. Is the physical diagnosis of below-knee superficial thrombophlebitis reliable?. Phlebologie 1999;28(3):93-6.
84. Lutter KS, Kerr TM, Roedersheimer LR, Lohr JM, Sampson MG. Superficial thrombophlebitis diagnosed by duplex scanning. Surgery 1991;110(1):42-6.
85. Martinelli I, Cattaneo M, Taioli E, De Stefano V, Chiusolo P, Mannucci PM. Genetic risk factors for superficial vein thrombosis. Thrombosis and Haemostasis 1999;82(4):1215-7.
86. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. Journal of Internal Medicine 1992;232(2):155-60.
87. Plate G, Eklof B, Jensen R, Ohlin P. Deep venous thrombosis, pulmonary embolism and acute surgery in thrombophlebitis of the long saphenous vein. Acta Chirurgia Scandinavica 1985;151(3):241-4.
88. Quenet S, Laporte S, Decousus H, Leizorovicz A, Epinat M, Mismetti P. STENOX Group. Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis. Journal of Vascular Surgery 2003;38(5):944-9.
89. Rücker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I2 in assessing heterogeneity may mislead. BMC Medical Research Methodology 2008;8:79.
90. Samlaska CP, James WD. Superficial thrombophlebitis I. Primary hypercoagulable states. Journal of the American Academy of Dermatology 1990;22(6 Pt 1):975-89.
91. Samlaska CP, James WD. Superficial thrombophlebitis II. Secondary hypercoagulable states. Journal of the American Academy of Dermatology 1990;23(1):1-18.
92. Skillman JJ, Kent KC, Porter DH, Kim D. Simultaneous occurrence of superficial and deep thrombophlebitis in the lower extremity. Journal of Vascular Surgery 1990;11(6):818-23.
93. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. Journal of Clinical Epidemiology 2001;54(10):1046-55.
94. Unno N, Mitsuoka H, Uchiyama T, Yamamoto N, Saito T, Ishimaru K, Kaneko H, Nakamura S. Superficial thrombophlebitis of the lower limbs in patients with varicose veins. Surgery Today 2002;32(5):397-401.
95. Verlato F, Zucchetta P, Prandoni P, Camporese G, Marzola MC, Salmistraro G, et al. An expectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh. Journal of Vascular Surgery 1999;30(6):1113-5.
96. Wichers IM, Di Nisio M, Buller HR, Middeldorp S. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Haematologica 2005;90(5):672-7.
97. Di Nisio M, Middeldorp S, Wichers IM. Treatment for superficial thrombophlebitis of the leg. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD004982.pub2]
98. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD004982.pub4]